Sparfloxacin selects gyrase mutations in first-step Mycoplasma hominis mutants, whereas ofloxacin selects topoisomerase IV mutations.
about
Molecular mechanism of fluoroquinolones resistance in Mycoplasma hominis clinical isolates.Cloning and nucleotide sequence of the DNA gyrase (gyrA) gene from Mycoplasma hominis and characterization of quinolone-resistant mutants selected in vitro with trovafloxacin.Contribution of topoisomerase IV mutation to quinolone resistance in Mycoplasma genitalium.Characterization of mutations in DNA gyrase and topoisomerase IV Involved in quinolone resistance of Mycoplasma gallisepticum mutants obtained in vitro.In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectivelyRelationship between danofloxacin PK/PD parameters and emergence and mechanism of resistance of Mycoplasma gallisepticum in In Vitro model
P2860
Sparfloxacin selects gyrase mutations in first-step Mycoplasma hominis mutants, whereas ofloxacin selects topoisomerase IV mutations.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Sparfloxacin selects gyrase mu ...... ts topoisomerase IV mutations.
@ast
Sparfloxacin selects gyrase mu ...... ts topoisomerase IV mutations.
@en
type
label
Sparfloxacin selects gyrase mu ...... ts topoisomerase IV mutations.
@ast
Sparfloxacin selects gyrase mu ...... ts topoisomerase IV mutations.
@en
prefLabel
Sparfloxacin selects gyrase mu ...... ts topoisomerase IV mutations.
@ast
Sparfloxacin selects gyrase mu ...... ts topoisomerase IV mutations.
@en
P2093
P2860
P356
P1476
Sparfloxacin selects gyrase mu ...... cts topoisomerase IV mutations
@en
P2093
F D Cartwright
K E Sjöström
P2860
P304
P356
10.1128/AAC.43.10.2493
P407
P577
1999-10-01T00:00:00Z